[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100299295":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":32,"locations":43,"responsibleParty":195,"collaborators":12,"id":197,"slug":198,"hasResults":199,"nctId":200,"briefTitle":201,"officialTitle":202,"acronym":203,"eligibilityCriteria":204,"healthyVolunteers":199,"sex":205,"minAge":206,"maxAge":207,"enrollmentInfo":208,"targetDuration":12,"studyType":211,"phases":212,"briefSummary":214,"conditions":215,"keywords":217,"overallStatus":220,"whyStopped":12,"lastUpdateSubmitDate":221,"lastUpdatePostDateStruct":222,"startDateStruct":225,"completionDateStruct":227,"leadSponsor":229,"locationsCount":230},{"fullName":5,"class":6},"Invero Pharma, Inc.","INDUSTRY",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"TH\u002FTTM","NO_INTERVENTION","Protocol-directed standard of care (including TH\u002FTTM) dictated by the 2015 guidelines for Post-Cardiac Arrest Care from the American Heart Association and the European Resuscitation Council. Mechanical Ventilation delivered by individual site-sanctioned ventilator.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"TH\u002FTTM plus Xenon","ACTIVE_COMPARATOR","50% xenon gas in addition to standard of care, including therapeutic hypothermia\u002Ftargeted temperature management (TH\u002FTTM).",[18],"Combination Product: Xenon",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"COMBINATION_PRODUCT","Xenon","50% xenon by inhalation, delivered by customized xenon delivery system, that includes a ventilator, for the 24h period of TH\u002FTTM. The inhalation therapy is provided in combination with protocol-directed Post-Cardiac Arrest Care dictated by the 2015 guidelines from the American Heart Association and the European Resuscitation Council.",[14],[26],"XENEX",[28],{"name":29,"affiliation":30,"role":31},"Steffen Stuerzebecher, M.D.","CMO Invero Pharma","STUDY_DIRECTOR",[33,39],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},"Clinical Trial Support at Invero Pharma","CONTACT","(862) 800-7788","801","dstefanelli@inveropharma.com",{"name":40,"role":35,"phone":36,"phoneExt":41,"email":42},"Regulatory Affairs at Invero Pharma","803","mnapoletano@inverohealth.com",[44,64,74,95,111,128,145,161,177,187],{"facility":45,"status":12,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Hartford Hospital","Hartford","Connecticut","06102","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-72.68509,41.76371,{"lat":55,"lon":54},[58,61],{"name":59,"role":35,"phone":12,"phoneExt":12,"email":60},"William Roman","William.Roman@hhchealth.org",{"name":62,"role":63,"phone":12,"phoneExt":12,"email":12},"Antonio Fernandez, MD","PRINCIPAL_INVESTIGATOR",{"facility":65,"status":12,"city":66,"state":67,"zip":68,"country":49,"countryCode":50,"cosmosGeoPoint":69,"geoPoint":73,"contacts":12},"University of Florida","Gainesville","Florida","32611",{"type":52,"coordinates":70},[71,72],-82.32483,29.65163,{"lat":72,"lon":71},{"facility":75,"status":12,"city":76,"state":77,"zip":78,"country":49,"countryCode":50,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Memorial Hospital at Gulfport","Gulfport","Mississippi","39503",{"type":52,"coordinates":80},[81,82],-89.09282,30.36742,{"lat":82,"lon":81},[85,89,93],{"name":86,"role":35,"phone":87,"phoneExt":12,"email":88},"Brandy Williams","228-575-2480","bwilliams@mhg.com",{"name":90,"role":35,"phone":91,"phoneExt":12,"email":92},"Katherine F. Green, BSN, RN","228-575-2518","kgreen@mhg.com",{"name":94,"role":63,"phone":12,"phoneExt":12,"email":12},"Joseph R. Bosarge, M.D.",{"facility":96,"status":12,"city":97,"state":98,"zip":99,"country":49,"countryCode":50,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"University Nebraska Medical Center","Omaha","Nebraska","68198",{"type":52,"coordinates":101},[102,103],-95.94043,41.25626,{"lat":103,"lon":102},[106,109],{"name":107,"role":35,"phone":12,"phoneExt":12,"email":108},"Lace D Sindt, BS","lace.sindt@unmc.edu",{"name":110,"role":63,"phone":12,"phoneExt":12,"email":12},"James N Sullivan, MD",{"facility":112,"status":12,"city":113,"state":114,"zip":115,"country":49,"countryCode":50,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"University at Buffalo","Buffalo","New York","14203",{"type":52,"coordinates":117},[118,119],-78.87837,42.88645,{"lat":119,"lon":118},[122,126],{"name":123,"role":35,"phone":124,"phoneExt":12,"email":125},"Robin M. Stein, RN, BSN","716-888-4859","rmstein3@buffalo.edu",{"name":127,"role":63,"phone":12,"phoneExt":12,"email":12},"Vijay Iyer, MD",{"facility":129,"status":12,"city":130,"state":131,"zip":132,"country":49,"countryCode":50,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"Wexner Medical Center, Ohio State University","Columbus","Ohio","43210",{"type":52,"coordinates":134},[135,136],-82.99879,39.96118,{"lat":136,"lon":135},[139,143],{"name":140,"role":35,"phone":141,"phoneExt":12,"email":142},"January Kim, BS","614-293-3559","January.Kim@osumc.edu",{"name":144,"role":63,"phone":12,"phoneExt":12,"email":12},"Uribe Alberto, MD",{"facility":146,"status":12,"city":147,"state":148,"zip":149,"country":49,"countryCode":50,"cosmosGeoPoint":150,"geoPoint":154,"contacts":155},"Baptist Memorial Hospital, Baptist Clinical Research Institute","Memphis","Tennessee","38120",{"type":52,"coordinates":151},[152,153],-90.04898,35.14953,{"lat":153,"lon":152},[156,159],{"name":157,"role":35,"phone":12,"phoneExt":12,"email":158},"Mildred Jenkins","Mildred.Jenkins@BMHCC.org",{"name":160,"role":63,"phone":12,"phoneExt":12,"email":12},"Patricia Hopkins",{"facility":162,"status":12,"city":163,"state":164,"zip":165,"country":49,"countryCode":50,"cosmosGeoPoint":166,"geoPoint":170,"contacts":171},"Houston Methodist Research Institute","Houston","Texas","77030",{"type":52,"coordinates":167},[168,169],-95.36327,29.76328,{"lat":169,"lon":168},[172,175],{"name":173,"role":35,"phone":12,"phoneExt":12,"email":174},"Digant Jariwala","djariwala@houstonmethodist.org",{"name":176,"role":63,"phone":12,"phoneExt":12,"email":12},"Janice Zimmerman, MD",{"facility":178,"status":12,"city":179,"state":12,"zip":12,"country":180,"countryCode":181,"cosmosGeoPoint":182,"geoPoint":186,"contacts":12},"Aalborg University Hospital","Aalborg","Denmark","DK",{"type":52,"coordinates":183},[184,185],9.9187,57.048,{"lat":185,"lon":184},{"facility":188,"status":12,"city":189,"state":12,"zip":12,"country":180,"countryCode":181,"cosmosGeoPoint":190,"geoPoint":194,"contacts":12},"University Hospital, Rigshospitalet, Blegdamsvej 9","Copenhagen",{"type":52,"coordinates":191},[192,193],12.56553,55.67594,{"lat":193,"lon":192},{"type":196,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100299295","phase-3-xenon-for-neuroprotection-during-post-cardiac-arrest-syndrome-in-comatose-survivors-of-an-out-of-hospital-cardiac-arrest-100299295",false,"NCT03176186","Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest","XePOHCAS - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome","XePOHCAS","Inclusion Criteria:\n\n1. Age at least 18 years but less than or equal to 80 years\n2. Presumed cardiac cause of arrest\n3. Sustained (\\>20 minutes) spontaneous circulation upon arrival in the emergency department\n4. No response to verbal commands on arrival to emergency department and prior to randomization (Glasgow Coma Scale score of \\\u003C8)\n5. Attending decision that patient is eligible for TTM\n\nExclusion Criteria:\n\n1. Written do not attempt resuscitation reported to providers before randomization\n2. Traumatic etiology of arrest, defined as concomitant blunt, penetrating, or burn-related injury, or uncontrolled bleeding or exsanguination\n3. Suspected or known stroke or intracranial hemorrhage\n4. Unwitnessed cardiac arrest\n5. No-flow (cardiac arrest to initiation of cardiopulmonary resuscitation\u002Fdefibrillation) time of \\>10 minutes\n6. Sustained restoration of spontaneous circulation (ROSC) greater than 30- minutes post-arrest\n7. Interval from arrival at the emergency department to randomization for intervention of \\>4 hours.\n8. Hypothermia (\\\u003C30°C core temperature)\n9. Bed-bound prior to cardiac arrest\n10. Unconsciousness before cardiac arrest (cerebral trauma, spontaneous cerebral hemorrhage, intoxication etc.)\n11. Coagulopathy\n12. Systolic arterial pressure \\\u003C80 mmHg or mean arterial pressure \\\u003C60 mmHg lasting more than 30 minutes after ROSC\n13. Known pregnancy\n14. Have received an investigational drug, device, or biologic product within 30-days\n15. Known terminal phase of chronic illness\n16. Hypoxemia (SaO2 \\\u003C85%) for \\>15 minutes after ROSC\n17. Inability to maintain SaO2 \\>90% on an FiO2 of 50%\n18. Having any other clinically significant laboratory abnormality, medical condition (such as intrinsic liver disease or severe chronic obstructive pulmonary disease), or social circumstance that, in the investigator's opinion, makes it inappropriate for the patient to participate in this clinical trial\n19. Logistically impossible to provide intervention\n20. Have any condition that would impact the evaluation of modified Rankin Scale (mRS)","ALL","18 Years","80 Years",{"count":209,"type":210},1436,"ESTIMATED","INTERVENTIONAL",[213],"PHASE3","XePOHCAS: Prospective, randomized, multicenter interventional trial in adult subjects with out-of-hospital cardiac arrest comparing treatment with standard-of-care post-cardiac arrest intensive care (which is targeted temperature management \\[TTM\\]) to xenon by inhalation plus standard-of-care post-cardiac arrest intensive care (including TTM).",[216],"Post-Cardiac Arrest Syndrome",[218,219],"ischemic-reperfusion injury","out of hospital cardiac arrest","NOT_YET_RECRUITING","2025-04-02",{"date":223,"type":224},"2025-04-03","ACTUAL",{"date":226,"type":210},"2026-03",{"date":228,"type":210},"2030-05",{"name":5,"class":6},10]